FDA Approves Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara

RALEIGH, N.C., Oct. 14, 2024 /PRNewswire/ — Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that the U.S. Food and Drug…Original Article